{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:14:31Z","timestamp":1791195271352,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Intrahepatic cholangiocarcinoma (ICC), a malignancy originating from the epithelial cells of bile ducts, has shown a notable rise in its incidence over the years. It ranks as the second most frequent primary liver cancer after hepatocellular carcinoma. This study investigates how independent prognostic factors, specifically, age and tumor stage, interact to impact mortality in ICC patients. Furthermore, it examines the clinical features, survival rates, and prognostic indicators of ICC cases diagnosed between 2010 and 2017. Methods: Using data from 5083 patients obtained from the Surveillance, Epidemiology, and End Results (SEER) database, this study evaluated demographic and clinical factors alongside overall mortality (OM) and cancer-specific mortality (CSM). Variables achieving a p-value below 0.1 in univariate Cox regression analysis were incorporated into multivariate Cox regression models to identify independent prognostic factors. Hazard ratios (HRs) exceeding 1 were interpreted as markers of poor prognosis. Additionally, this study explored the interaction between age and tumor stage in shaping survival outcomes. Results: The multivariate Cox proportional hazards analysis indicated higher OM in males (HR = 1.19, 95% CI: 1.12\u20131.26, p &lt; 0.01) and residents of metropolitan counties with populations exceeding 250,000 (HR = 1.15, 95% CI: 1.01\u20131.31, p &lt; 0.05). Conversely, lower OM was observed in individuals aged 40\u201359 years (HR = 0.58, 95% CI: 0.38\u20130.89, p &lt; 0.05), those aged 60\u201379 years (HR = 0.65, 95% CI: 0.43\u20130.98, p &lt; 0.05), and patients who received radiation therapy (HR = 0.78, 95% CI: 0.72\u20130.85, p &lt; 0.01), chemotherapy (HR = 0.54, 95% CI: 0.51\u20130.58, p &lt; 0.01), or surgery (HR = 0.29, 95% CI: 0.26\u20130.31, p &lt; 0.01). For CSM, males exhibited higher risks (HR = 1.17, 95% CI: 1.10\u20131.25, p &lt; 0.01), as did individuals in metropolitan counties with populations over 250,000 (HR = 1.18, 95% CI: 1.03\u20131.35, p &lt; 0.05). Reduced CSM was observed in patients aged 40\u201359 years (HR = 0.52, 95% CI: 0.34\u20130.79, p &lt; 0.01), those aged 60\u201379 years (HR = 0.57, 95% CI: 0.38\u20130.86, p &lt; 0.01), and those undergoing radiation therapy (HR = 0.76, 95% CI: 0.70\u20130.83, p &lt; 0.01), chemotherapy (HR = 0.55, 95% CI: 0.51\u20130.59, p &lt; 0.01), or surgery (HR = 0.27, 95% CI: 0.25\u20130.30, p &lt; 0.01). When examining the interaction between age and tumor stage, higher OM was observed in patients aged 40\u201359 with tumors involving lymph nodes (HR = 1.26, 95% CI: 1.14\u20132.67, p &lt; 0.05). Similarly, CSM was elevated in patients aged 40\u201359 with lymph node involvement alone (HR = 2.60, 95% CI: 1.26\u20135.36, p &lt; 0.05) or with direct spread (HR = 2.81, 95% CI: 1.04\u20137.61, p &lt; 0.05). Among those aged 60\u201379, higher CSM was noted in cases with lymph node involvement only (HR = 2.24, 95% CI: 1.11\u20134.50, p &lt; 0.05) or lymph node involvement accompanied by direct extension (HR = 2.93, 95% CI: 1.10\u20137.82, p &lt; 0.05). Conclusions: This retrospective analysis, utilizing data from the SEER database, provides new insights into mortality patterns in intrahepatic cholangiocarcinoma (ICC). This study identifies a significant interplay between two key prognostic factors, emphasizing their collective role in influencing mortality outcomes. Despite the predominance of advanced-stage diagnoses, our analysis underscores the substantial survival benefits associated with treatment interventions, with surgical procedures demonstrating the most pronounced impact. These findings highlight the importance of recognizing patients who may benefit from timely and intensive therapeutic strategies. Furthermore, the results underscore the need for future prospective randomized studies to deepen our understanding of these interactions in ICC, particularly as advancements in precision oncology continue to refine patient care.<\/jats:p>","DOI":"10.3390\/diseases13020031","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T06:39:51Z","timestamp":1737959991000},"page":"31","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Age and Tumor Stage Interplay in Intrahepatic Cholangiocarcinoma: Prognostic Factors, Mortality Trends, and Therapeutic Implications from a SEER-Based Analysis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2133-2480","authenticated-orcid":false,"given":"Ayrton","family":"Bangolo","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh K.","family":"Nagesh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrian Hoang-Vu","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Sens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Elias","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Amoozgar","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Tomasino","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izage","family":"Kianifar Aguilar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Mansour","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gagen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-4970","authenticated-orcid":false,"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvarinder","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisrene","family":"Jebara","sequence":"additional","affiliation":[{"name":"Columbia University School of Nursing, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Madigan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Candela","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohaa","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Giunta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhangi","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6422-3961","authenticated-orcid":false,"given":"Auda","family":"Auda","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Peej","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timophyll Y. H.","family":"Fong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simcha","family":"Weissman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Printhia Matshi","family":"Lihau","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Congolese National Cancer Control Center, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-2326","authenticated-orcid":false,"given":"John","family":"Bukasa-Kakamba","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nuclear Medicine, Kinshasa University Clinics, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","article-title":"Intrahepatic cholangiocarcinoma","volume":"28","author":"Pawlik","year":"2019","journal-title":"Surg. Oncol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: The AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2147\/OTT.S93629","article-title":"Intrahepatic cholangiocarcinoma: Current perspectives","volume":"22","author":"Buettner","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhang, L., Chen, C., Chai, D., Kuang, T., Deng, W., and Wang, W. (2023). Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1090392"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/HMER.S278136","article-title":"Challenges and opportunities for treating intrahepatic cholangiocarcinoma","volume":"2","author":"Serifis","year":"2021","journal-title":"Hepatic Med. Evid. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","article-title":"Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management","volume":"379","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wasilewicz, M.P., and Becht, R. (2023). Intrahepatic Cholangiocarcinoma\u2014Where Are We Now and Where Are We Going to?. Medicina, 59.","DOI":"10.3390\/medicina59040729"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/j.crad.2014.08.003","article-title":"Diagnosis and management of intrahepatic cholangiocarcinoma: A comprehensive update for the radiologist","volume":"69","author":"Baheti","year":"2014","journal-title":"Clin. Radiol."},{"key":"ref_12","first-page":"383","article-title":"Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment","volume":"16","author":"Bragazzi","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5604\/01.3001.0010.8659","article-title":"Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995\u20132014","volume":"17","author":"Antwi","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/a-2207-5519","article-title":"Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis\u2013a retrospective cohort study","volume":"62","author":"Schramm","year":"2024","journal-title":"Z. F\u00fcr Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"Yamamoto","year":"2004","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yao, K.J., Jabbour, S., Parekh, N., Lin, Y., and Moss, R.A. (2016). Increasing mortality in the United States from cholangiocarcinoma: An analysis of the National Center for Health Statistics Database. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0527-z"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_22","first-page":"1934","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"Database Abstr. Rev. Eff. Qual. Assess. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xing, H., Tan, B., Yang, C., and Zhang, M. (2022). Incidence trend and competing risk analysis of patients with intrahepatic cholangiocarcinoma: A population-based study. Front. Med., 9.","DOI":"10.3389\/fmed.2022.846276"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yu, T.H., Chen, X., Zhang, X.H., Zhang, E.C., and Sun, C.X. (2021). Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: A population-based study. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-83149-5"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21037\/cco.2018.07.02","article-title":"Intrahepatic cholangiocarcinoma surgery: The impact of lymphadenectomy","volume":"7","author":"Lendoire","year":"2018","journal-title":"Chin. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4251\/wjgo.v5.i7.171","article-title":"Chemotherapy for cholangiocarcinoma: An update","volume":"5","author":"Aix","year":"2013","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4254\/wjh.v13.i9.1003","article-title":"Advances in the management of cholangiocarcinoma","volume":"13","author":"Zori","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lauterio, A., De Carlis, R., Centonze, L., Buscemi, V., Incarbone, N., Vella, I., and De Carlis, L. (2021). Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma. Cancers, 13.","DOI":"10.3390\/cancers13153657"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-019-07260-8","article-title":"Impact of anatomical versus non-anatomical liver resection on short-and long-term outcomes for patients with intrahepatic cholangiocarcinoma","volume":"26","author":"Si","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000516880","article-title":"Twenty years of radiation therapy of unresectable intrahepatic cholangiocarinoma: Internal or external? a systematic review and meta-analysis","volume":"10","author":"Yu","year":"2021","journal-title":"Liver Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ctrv.2018.05.001","article-title":"The management of adolescents and young adults with cancer","volume":"67","author":"Hughes","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Weng, M.T., Chao, K.H., Tung, C.C., Chang, H.C., Shih, I.L., Lin, B.R., Shieh, M.J., Shun, C.T., Wong, J.M., and Wei, S.C. (2022). Characteristics of primary signet ring cell carcinoma of colon and rectum: A case control study. BMC Gastroenterol., 22.","DOI":"10.1186\/s12876-022-02258-1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bjs.4015","article-title":"Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age","volume":"90","author":"Liang","year":"2003","journal-title":"J. Br. Surg."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/2\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:56Z","timestamp":1759919756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/2\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["diseases13020031"],"URL":"https:\/\/doi.org\/10.3390\/diseases13020031","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]}}}